Clinical trials
Phase 1 Erectile Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 5 |
| 2010 | 11 |
| 2011 | 3 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 7 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 10 |
| 2023 | 1 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
| Unknown status | 6 |
| Not yet recruiting | 5 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| VIVUS LLC | 9 |
| Vigonvita Life Sciences | 6 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 5 |
| Hanmi Pharmaceutical Company Limited | 4 |
| Aspargo Labs, Inc | 3 |
| SK Chemicals Co., Ltd. | 3 |
| Bayer | 2 |
| Asan Medical Center | 1 |
| Assaf-Harofeh Medical Center | 1 |
| Assiut University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Erectile Dysfunction | 65 |
| Prostatic Hyperplasia | 4 |
| Diabetes Mellitus, Type 1 | 3 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Penile Induration | 2 |
| Pulmonary Arterial Hypertension | 2 |
| Renal Insufficiency | 2 |
| Alzheimer Disease | 1 |
| Arthritis | 1 |
Trials
Showing 26 to 50 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.